CFDE Data Portal | Search LINC02055

	Label	Description
	LINC02055 Gene (Entity type)	ENSG00000254101 - long intergenic non-protein coding RNA 2055
	GSE173483 nutlin-3 U2OS 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE56010 adenosine 4 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE202434 GSE202438 talazoparib 4 v 11 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE95077 amiloride 5 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE126651 PRMT5 MTAP inhibition 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE172494 nicotinamide 3 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE228106 paclitaxel R1192 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE172409 dopamine neuron 1 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE80098 GSE80366 progesterone 0 v 4 human up Gene Set (Entity type)	A Gene Set from LINCS

LINC02055

ENSG00000254101 - long intergenic non-protein coding RNA 2055

GSE173483 nutlin-3 U2OS 1 v 0 human dn

A Gene Set from LINCS

GSE56010 adenosine 4 v 1 human dn

A Gene Set from LINCS

GSE202434 GSE202438 talazoparib 4 v 11 human up

A Gene Set from LINCS

GSE95077 amiloride 5 v 4 human dn

A Gene Set from LINCS

GSE126651 PRMT5 MTAP inhibition 1 v 2 human up

A Gene Set from LINCS

GSE172494 nicotinamide 3 v 1 human dn

A Gene Set from LINCS

GSE228106 paclitaxel R1192 3 v 2 human dn

A Gene Set from LINCS

GSE172409 dopamine neuron 1 v 4 human dn

A Gene Set from LINCS

GSE80098 GSE80366 progesterone 0 v 4 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.